Stocks Cut Gains, Despite Oil Rebound, After Gilead Trial Disappoints

The market was flat on Thursday as Wall Street digested news of Gilead’s possible coronavirus treatment.

Read the full post on Forbes - Healthcare

Sergei Klebnikov, Forbes Staff